Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Nephropathy? 101 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Nephropathy have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.1% of all adverse event reports for ATORVASTATIN.

101
Reports of Nephropathy with ATORVASTATIN
0.1%
of all ATORVASTATIN reports
2
Deaths
14
Hospitalizations

How Dangerous Is Nephropathy From ATORVASTATIN?

Of the 101 reports, 2 (2.0%) resulted in death, 14 (13.9%) required hospitalization, and 6 (5.9%) were considered life-threatening.

Is Nephropathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 101 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Nephropathy?

LANSOPRAZOLE (1,332) OMEPRAZOLE (1,241) ESOMEPRAZOLE (1,151) EMTRICITABINE\TENOFOVIR DISOPROXIL (1,089) TENOFOVIR DISOPROXIL (1,033) PANTOPRAZOLE (892) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (618) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (342) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (300) DEXLANSOPRAZOLE (259)

Which ATORVASTATIN Alternatives Have Lower Nephropathy Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Nephropathy Reports All Drugs Causing Nephropathy ATORVASTATIN Demographics